JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266376

Human GNPDA1 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

GNPDA1 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2.

View Alternative Names

EC 3.5.99.6, GNPI, GNPI1_HUMAN, GlcN6P deaminase 1, Glucosamine-6-phosphate deaminase 1, Glucosamine-6-phosphate isomerase 1, HLN, KIAA0060, Oscillin, Putative glucosamine 6 phosphate isomerase

1 Images
Sanger Sequencing - Human GNPDA1 knockout HEK-293T cell line (AB266376)
  • Sanger seq

Unknown

Sanger Sequencing - Human GNPDA1 knockout HEK-293T cell line (AB266376)

Homozygous : Insertion of the selection cassette in exon 2

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266376-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266376 Human GNPDA1 knockout HEK-293T cell line", "number":"AB266376-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266376-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266376 Human GNPDA1 knockout HEK-293T cell line", "number":"AB266376-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
GNPDA1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

GNPDA1 also known as glucosamine-6-phosphate deaminase 1 is an enzyme that plays an important role in the hexosamine biosynthesis pathway. This protein has a molecular mass of approximately 33 kDa. GNPDA1 is expressed in various human tissues with higher levels noticeable in the kidney and liver. It catalyzes the conversion of glucosamine-6-phosphate into fructose-6-phosphate and ammonia a reaction important for cellular carbohydrate metabolism.
Biological function summary

Glucosamine-6-phosphate deaminase 1 influences cell processes through its enzymatic activity. This enzyme functions as a monomer not requiring complex formation to exert its biological role. By contributing to the hexosamine biosynthetic pathway GNPDA1 affects key physiological functions including cell signaling and protein glycosylation. Its activity can influence cellular responses to nutrient availability and metabolic stress.

Pathways

The enzyme glucosamine-6-phosphate deaminase 1 plays a role in the hexosamine biosynthetic pathway and glycolysis. These pathways are essential for cellular energy metabolism and protein modification processes. GNPDA1 interacts with related proteins such as fructose-6-phosphate which links it to broader metabolic networks involving glucose utilization and adaptation to metabolic demands.

Alterations in GNPDA1 activity have implications for metabolic conditions including cancer and diabetes. Abnormal expression or function of this enzyme can disrupt metabolic homeostasis influencing cancer cell metabolism due to altered hexosamine pathway flux. GNPDA1's relationship with proteins involved in metabolic regulation such as those in the insulin signaling pathway can contribute to disease progression and present potential therapeutic targets.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com